BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1873917)

  • 1. Response of urinary angiotensin to challenges of the renin-angiotensin system.
    Boer P; Vos PF; Koomans HA; Rabelink AJ; Beutler JJ; Dorhout Mees EJ
    Clin Chim Acta; 1991 Jun; 199(2):195-204. PubMed ID: 1873917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary angiotensin excretion during sodium restriction and diuretics.
    Boer P; Koomans HA; Boer WH; Dorhout Mees EJ
    Nephrol Dial Transplant; 1989; 4(8):713-7. PubMed ID: 2510079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood.
    Fiselier TJ; Lijnen P; Monnens L; van Munster P; Jansen M; Peer P
    Eur J Pediatr; 1983 Oct; 141(1):3-7. PubMed ID: 6315441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
    Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
    Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of plasma angiotensin I converting enzyme in regulation of renin-angiotensin system activity in patients with essential hypertension.
    Ishida H; Shimamoto K; Ando T; Nishitani T; Hosoda S; Yokoyama T; Fukuyama S; Mori Y; Nakagawa H; Ogata H
    J Clin Hypertens; 1987 Dec; 3(4):681-4. PubMed ID: 2839630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of furosemide, captopril and indometacin on the renin-angiotensin system and the renal prostaglandins in anesthetized neonatal piglets.
    Joppich R; Weyer P; Eife R
    Arzneimittelforschung; 1995 Jul; 45(7):822-5. PubMed ID: 8573231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of captopril on urinary excretion of furosemide in hypertensive subjects.
    Fujimura A; Shimokawa Y; Ebihara A
    J Clin Pharmacol; 1990 Jun; 30(6):538-42. PubMed ID: 2191978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of hemorrhage and sodium depletion on plasma concentrations of angiotensin II and [des-Asp1]angiotensin II in the rat.
    Semple PF
    Endocrinology; 1980 Sep; 107(3):771-3. PubMed ID: 7398582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelation between the renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension.
    Ishida H; Shimamoto K; Nishitani T; Hosoda S; Yokoyama T; Nakahashi Y; Ando T; Tanaka S; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():329-36. PubMed ID: 3028077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins and the contractile effect of angiotensin I and II in the uterus isolated from ovariectomized rats. Influences of indomethacin and 17-beta estradiol.
    Chaud M; Viggiano M; Gimeno MF; Gimeno AL
    Prostaglandins Leukot Med; 1984 Nov; 16(2):225-34. PubMed ID: 6396653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular effects and metabolism of angiotensins and their metabolites in the isolated perfused rat kidney.
    Misumi J; Gonzales MF; Ogihara T; Corvol P; Ménard J
    Clin Exp Hypertens A; 1983; 5(7-8):1151-62. PubMed ID: 6357560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evidence that angiotensins I and II are formed by intracellular mechanism in juxtaglomerular cells.
    Naruse K; Inagami T; Celio MR; Workman RJ; Takii Y
    Hypertension; 1982; 4(3 Pt 2):70-4. PubMed ID: 6279509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of urinary angiotensins in humans.
    Vos PF; Boer P; Braam B; Koomans HA
    J Am Soc Nephrol; 1994 Aug; 5(2):215-23. PubMed ID: 7994001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of furosemide on angiotensin II-mediated prostaglandin I2 production in hypertensive subjects.
    Fujimura A; Ebihara A
    Eur J Clin Pharmacol; 1990; 39(2):113-5. PubMed ID: 2253658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibition on renal dysfunction induced by moderate potassium depletion in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Ikonomu E; Lenzi P; Marinelli M
    Clin Physiol; 1994 Mar; 14(2):205-22. PubMed ID: 8205752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of captopril-induced increase in plasma renin activity by propranolol.
    Goto A; Ishii M; Takeda T; Murao S
    Jpn Heart J; 1983 Jul; 24(4):633-40. PubMed ID: 6358580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of captopril-induced renin release by angiotensin II.
    Mersey JH; Ceballos L; Swartz S
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):575-9. PubMed ID: 2447408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.